Jon Moore

Jon Moore is CSO at Horizon and has been leading Horizon’s Target Validation and Drug Discovery efforts since late 2012. Prior to this, he enjoyed 10 years at Vernalis culminating in a role as Head of Biology, where he was responsible for cell biology, assay development and a management of a major research alliance with GSK. Jon’s research interests include cancer metabolism & signal transduction. His postdoctoral research focused on cell cycle control, first with Sally Kornbluth at Duke and then Nobel Prize winner, Tim Hunt, at Cancer Research UK’s Clare Hall labs. He holds a PhD from the University of Newcastle upon Tyne and is a Fellow of the Royal Society of Biology.